No Detail Found!

Evaluating the Efficacy of Artemisia annua L-derived Artemisinin in Alleviating Visceral Leishmaniasis in Animal Models

Author(s)
Zahraa Ahmed Ali Department of Biology, College of Science, Mustansiriyah University,Baghdad,Iraq
Hadeel Abdulatif Majeed Department of Biology, College of Science, Mustansiriyah University,Baghdad,Iraq
Abstract
The medicinal potential of Artemisia annua L., commonly known as sweet wormwood, has garnered significant attention due to its extraction of ART (Artemisinin ART drug) as a potent anti-malarial, antiviral, anti-inflammatory, and other therapeutic properties. With the urgency to address the neglected issue of VL in Iraq and the limitations of conventional antileishmanial therapies, The current study included two aspects: the first aspect in vitro focuses on exploring alternative treatments. Through a comprehensive in vitro assessment, we prepared ART extracts in varying concentrations (5, 10, 20, and 30 mg/ml) from Artemisia annua L And comparing its effect with pentostam (the traditional medicine used to treat leishmaniasis) at two different times: 24 and 48 hours. and examined their impact on the viability of visceral Leishmania parasite promastigote using the MTT assay, it turned out that the percentage of viability of the parasite in its promastigote stage decreased with increasing ART concentration, it also has an effect on parasite growth, as parasite growth decreases significantly with time and increasing concentration. The second aspects in vivo: investigation specifically focused on the effects of a 20 mg/ml concentration of ART drug on the livers of infected mice, revealing notable changes over a 21-day period. Our findings demonstrate the potential of the 20 mg/ml ART treatment, revealing distinct improvements in liver pathology over the course of treatment, emphasizing the promise of this alternative approach in combating VL.
Publication Details
Page(s) 1123-1129
Published Journal: Journal of Global Innovations in Agricultural Sciences, Volume: 12, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
Artemisinin, parasite growth, Leishmania donovani, visceral leishmaniasis, wormwood.
References
Abd A.N.,Mohammed S.T.,Al-Marjani M.F.,Salman J.A.S.,Salman S.D.,Habubi N.F. .2018 .Antiparasitic Effect of CdO NPS Synthesized by Simple Chemical Method SCM on Leishmania donovani in vivo and in vitroherbicide glyphosate. Mesopotemia Environmental journal, : 97-106.
Abreu-Silva A.L.,Calabrese K.S.,Mortara R.A.,Tedesco R.C.,Cardoso F.O.,Carvalho L.O. .2004 .Extracellular matrix alterations in experimental murine Leishmania amazonensis infection. Parasitology, 128 : 385-390.
Ali E.N.,Mohammed S.T.,Ajah H.A.,Jamal R. .2009 .Preparation a New SHE-Medium Replacement of RPMI1640-Medium using Oral Rehydration Solution. Journal of Global pharma Technology, 12 : 196-200.
Alves F.,Bilbe G.,Blesson S.,Goyal V.,Monnerat S.,Mowbray C. .2018 .Recent development of visceral leishmaniasis treatments: successes, pitfalls, and perspectives. Clinical microbiology reviews, 31 : 10-1128.
Al-Harmni K.I.,Rahemo Z.I.,Al-Khan H.I. .2012 .The effect of two fruit extracts and drugs on the liver of albino mice with induced leishmaniasis. Trends in Parasitology Research, 1 : 16-26.
Amat N.,Upur H.,Blažeković B. .2010 .In vivo hepatoprotective activity of the aqueous extract of Artemisia absinthium L. against chemically and immunologically induced liver injuries in mice. Journal of ethnopharmacology, 13 : 478-484.
Artan R.,Yilmaz A.,Akçam M.,Aksoy N.H. .2006 .Liver biopsy in the diagnosis of visceral leishmaniasis. Journal of gastroenterology and hepatology, 21 : 299-302.
Carter K.C.,Baillie A.J.,Alexander J.,Dolan T.F. .1988 .The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent. Journal of pharmacy and pharmacology, 40 : 370-373.
Colomba C.,Guccione C.,Rubino R.,Scalisi M.,Condemi A.,Bagarello S. . .. 2022. Third Case of Visceral Leishmaniasis in COVID-19: Mini Review Article. Pathogens, 11 : 913.
Croft S.L.,Olliaro P. .2011 .Leishmaniasis chemotherapy-challenges and opportunities. Clinical microbiology and infection, 17 : 1478-1483.
Das S.,Roy P.,Mondal S.,Bera T.,Mukherjee A. .2013 .One pot synthesis of gold nanoparticles and application in chemotherapy of wild and resistant type visceral leishmaniasis. Colloids and Surfaces B: Biointerfaces, 107 : 27-34.
Dias-Lopes G.,Zabala-Peñafiel A.,C. de AlbuquerqueMelo F.,Souza-Silva L.M. .2021 .Axenic amastigotes of Leishmania species as a suitable model for in vitro studies. Acta tropica, 220 : 105956.
Ghaffarifar F.,Heydari F.E.,Dalimi A.,Hassan Z.M.,Delavari M.,Mikaeiloo H. .2015 .Evaluation of apoptotic and antileishmanial activities of Artemisinin on promastigotes and BALB/C mice infected with Leishmania major. Iran. Journal of Parasitology, 10 : 258.
Ghosh S.,Verma A.,Kumar V.,Pradhan D.,Selvapandiyan A.,Salotra P. .2020 .Genomic and transcriptomic analysis for identification of genes and interlinked pathways mediating artemisinin resistance in Leishmania donovani. Genes, 11 : 1362.
Ibarra-Meneses A.V.,Corbeil A.,Wagner V.,Onwuchekwa C.,Fernandez-Prada C. .2022 .Identification of asymptomatic Leishmania infections: a scoping review. Parasites and vectors, 15 : 1-22.
Kadhem Z.A.,Aakool A.A.,Faraj S. A. .2021 .Pathological Changes of Visceral Leishmaniasis on Liver and Spleen in Experimentally Infected BALB/C Mice. Annals of the Romanian Society for Cell Biology, : 5078-5086.
Martinez de Narvajas I.,Díaz A.,Bassegoda O.,Carpio A.,Fuster C.,Valls M.E. .2019 .Acute liver failure due to visceral leishmaniasis in Barcelona: a case report. BMC infectious diseases, 19 : 1-5.
Mohamed S.T.,Ghadi H.H.,Kamal S.B.,Mohammed N.,Aja H.A. .2019 .Effect of Fusarium graminarum silver nanoparticles on liver tissue of infected mice of visceral leishmaniasis. Journal of Pharmaceutical Sciences and Research, 11 : 886-891.
Najm M.,Hadighi R,Heidari-Kharaji M.,Alipour M.,Hajizadeh M.,Rafiei-Sefiddashti R.,Badirzadeh A. .2021 .Anti-Leishmanial Activity of Artemisia persica, A. spicigera, and A. fragrance against Leishmania major. Iranian Journal of Parasitology, 16 : 464.
Sen R.,Saha P.,Sarkar A.,Ganguly S.,Chatterjee M. .2010 .Iron enhances generation of free radicals by Artemisinin causing a caspase-independent, apoptotic death in Leishmania donovani promastigotes. Free radical research, 44 : 1289-1295.
Taher J.H.,AL-Mulla Y.M.,Hummadi Y.M.,Al-Bashir N.M.,Al-Araji A.S. .2015 .Lactate dehydrogenase (LD), alkaline phosphatase (ALP) iso enzymatic patterns in Iraqi children with visceral leishmaniasis before and after treatment with stibogluconate. Journal of Parasitic Diseases, 40 : 277-284.
Uwah A.F.,Effiong B.O.,Obot J.S.,Obioku I.J.,Udoh A.E. .2022 .Therapeutic potential of concurrent administration of Hippocratea africana and Eremomastax speciosa in the treatment of Plasmodium berghei infected mice. Ibom Medical Journal, 15 : 166-174.
.2020 .Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. , : .
Xiong Y.,Huang J. .2021 .Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment. Chinese Medicine, 16 : 80.
Xu C.,Zhang H.,Mu L.,Yang X. .2020 .Artemisinin as anticancer drugs: novel therapeutic approaches, molecular mechanisms, and clinical trials. Frontiers in Pharmacology, 11 : 529881.
Zhang G.S.,Gerhard G.S. .2008 .Heme activates Artemisinin more efficiently than hemin, inorganic iron, or hemoglobin. Bioorganic and Medicinal Chemistry, 16 : 7853-7861.
0

Citations

0

Downloads

18

Views